Embed

Academic

Authors

Mary C. Spellman

Mary C. Spellman,University of California San Diego,Dermatology,Diseases,Immunology

Edit

Mary C. Spellman

University of California San Diego

Publications: 14 | Citations: 191

Fields: Dermatology, Diseases, Immunology

Collaborated with 39 co-authors from 1995 to 2011 | Cited by 609 authors

Cumulative Annual

Sort by:

Publications (14)

BibTeX | RIS | RefWorks Download

751 TREATMENT OF CHRONIC HEPATITIS B INFECTION WITH DV601, A THERAPEUTIC VACCINE

Journal: Journal of Hepatology - J HEPATOL , vol. 54, pp. S302-S302, 2011

300 PHASE 1B DOSE-ESCALATION STUDY OF SD101, A NOVEL THERAPEUTIC TLR-9 AGONIST, IN TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS (Citations: 1)

, ,

Journal: Journal of Hepatology - J HEPATOL , vol. 52, pp. S126-S126, 2010

Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects (Citations: 16)

, , , ,

Journal: Journal of Allergy and Clinical Immunology - J ALLERG CLIN IMMUNOL , vol. 116, no. 4, pp. 780-788, 2005

A randomized, double-blind, double-dummy, placebo-controlled study of the safety and efficacy of ketoconazole foam, 2%, versus ketoconazole 2% cream in the treatment of seborrheic dermatitis 1 1 Disclosure not available at press time

, , ,

Journal: Journal of The American Academy of Dermatology - J AMER ACAD DERMATOL , vol. 50, no. 3, pp. P103-P103, 2004

Clindamycin phosphate foam, 1%, versus clindamycin phosphate gel, 1%, for the treatment of acne vulgaris; results of a phase III study 1 1 Disclosure not available at press time

, , ,

Journal: Journal of The American Academy of Dermatology - J AMER ACAD DERMATOL , vol. 50, no. 3, pp. P24-P24, 2004

Sort by:

Citations (191 times by 189 publications)

Electricity trade and GHG emissions: Assessment of Quebec's hydropower in the Northeastern American market (2006–2008)

, , ,

Journal: Energy Policy - ENERG POLICY , vol. 39, no. 3, pp. 1711-1721, 2011

Short communication: Suitability of fluorescence spectroscopy for characterization of commercial milk of different composition and origin

, , , ,

Journal: Journal of Dairy Science - J DAIRY SCI , vol. 94, no. 11, pp. 5375-5380, 2011

First-principles study on structural and electronic properties of copper nanowire encapsulated into GaN nanotube

, , ,

Journal: Physica B-condensed Matter - PHYSICA B , vol. 406, no. 18, pp. 3502-3507, 2011

Platinum(II)-bis-(N-heterocyclic carbene) complexes: synthesis, structure and catalytic activity in the hydrosilylation of alkenes

, ,

Journal: Journal of Organometallic Chemistry - J ORGANOMET CHEM , vol. 696, no. 17, pp. 2918-2927, 2011

A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis (Citations: 105)

, , , , , , , , , , ,

Published in 2010.

Comments

Co-authors (39)

Journals (8)

Keywords (25)

Mary C. Spellman,University of California San Diego,Dermatology,Diseases,Immunology

Publications (14)

BibTeX | RIS | RefWorks Download

751 TREATMENT OF CHRONIC HEPATITIS B INFECTION WITH DV601, A THERAPEUTIC VACCINE

300 PHASE 1B DOSE-ESCALATION STUDY OF SD101, A NOVEL THERAPEUTIC TLR-9 AGONIST, IN TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS (Citations: 1)

Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects (Citations: 16)

A randomized, double-blind, double-dummy, placebo-controlled study of the safety and efficacy of ketoconazole foam, 2%, versus ketoconazole 2% cream in the treatment of seborrheic dermatitis 1 1 Disclosure not available at press time

Clindamycin phosphate foam, 1%, versus clindamycin phosphate gel, 1%, for the treatment of acne vulgaris; results of a phase III study 1 1 Disclosure not available at press time

Citations (191 times by 189 publications)

Electricity trade and GHG emissions: Assessment of Quebec's hydropower in the Northeastern American market (2006–2008)

Short communication: Suitability of fluorescence spectroscopy for characterization of commercial milk of different composition and origin

First-principles study on structural and electronic properties of copper nanowire encapsulated into GaN nanotube

Platinum(II)-bis-(N-heterocyclic carbene) complexes: synthesis, structure and catalytic activity in the hydrosilylation of alkenes

A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis (Citations: 105)


	View FAQ about top research areas and Fields of study

Mary C. Spellman,University of California San Diego,Dermatology,Diseases,Immunology

Publications (14) BibTeX | RIS | RefWorks Download

300 PHASE 1B DOSE-ESCALATION STUDY OF SD101, A NOVEL THERAPEUTIC TLR-9 AGONIST, IN TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS (Citations: 1)

Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects (Citations: 16)

A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis (Citations: 105)

Publications (14)

BibTeX | RIS | RefWorks Download